Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection
Trial details
- Registry ID
- NCT03421743
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as rh-GM-CSF
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) InfectionNCT03421743 | SVRA | Phase 2 | Completed | 2019-10-15Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |